Manuel Gutiérrez de Ravé: My Personal Takeaways from 39th International ISBT Annual Congress
Manuel Gutiérrez de Ravé, Real-World Evidence (RWE) Scientist at Terumo Blood and Cell Technologies, shared a post on LinkedIn:
“The 39th International ISBT Annual Congress once again proved to be an unparalleled forum for scientific dissemination and educational training, fostering collaboration among the diverse stakeholders of the transfusion medicine community.
Here are my personal takeaways of this year:
Donor Management: following recurrent quality-monitoring failures and blood product discards is important to assess potential underlying conditions that may affect donor health.
Hemovigilance:. A fully interconnected ecosystem is essential to ensure vein-to-vein safety, with traceability serving as the foundation rather than merely a compliance exercise.
Multi-omic insights into blood products during storage, together with donor variability, will help shape blood banking and personalised medicine and improve transfusion effectiveness.
PBM in Surgical settings has consistently shown that restrictive transfusion strategies provide equal or superior clinical benefits compared with liberal strategies.
New blood products: ABO universal blood, achieved through enzymatic conversion to group O, and synthetic oxygen carriers may become important additions to blood supply inventories in crisis settings and remote areas in the coming years.
Artificial intelligence: Semantic search, clustering, and Retrieval-Augmented Generation (RAG) can be combined to create more accurate, context-aware, and scalable generative AI systems, drastically reducing the risk of AI hallucinations.
Finally, I was thrilled to meet many TBCT colleagues from other regions in person, exchange ideas, build new relationships, and collaborate to pursue excellence in blood technologies.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering